Please login to the form below

Not currently logged in
Email:
Password:

CNS

This page shows the latest CNS news and features for those working in and with pharma, biotech and healthcare.

Theranexus takes Alzheimer’s drug combo into clinic

Theranexus takes Alzheimer’s drug combo into clinic

Theranexus. The biotech’s platform is based on combining CNS drugs targeting neurons with a glial cell-modulating agent that it thinks can improve the response to the primary therapy, and

Latest news

More from news
Approximately 4 fully matching, plus 170 partially matching documents found.

Latest Intelligence

  • A quest for innovative solutions A quest for innovative solutions

    PRISM has matured into an artery of new opportunities such as its collaboration on RADAR-CNS (Remote Assessment of Disease and Relapse - Central Nervous System), an initiative that aims to develop

  • The good, the bad and the ugly The good, the bad and the ugly

    Pfizer has large sales in CNS - $8.5bn in 2017. The majority come through Lyrica ($5bn). ... In Europe, a patent dispute over Lyrica became arguably the biggest CNS story in recent years.

  • Pharma deals continue to slide Pharma deals continue to slide

    1, 410 (upfront 80). WuXi Biologics and Gloria Pharma (CN). Arcus Biosciences (US). ... 163. Mologen (DE). iPharma (CN). Binding term sheet for licensing and co-development.

  • Deal Watch - May 2017 Deal Watch - May 2017

    Peptidream (CN). Janssen (US). Licence. Peptide discovery platform. Up to 1, 150.

  • Deal Watch September 2016 Deal Watch September 2016

    210. Ligand / Seelos. Licence. 4 programmes including aplindore for CNS disorders.

More from intelligence
Approximately 0 fully matching, plus 38 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 25 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...
Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...

Infographics